Amesite's Proprietary AI Powers Caregiver Solution Enables Contract Growth in Large Segments Amesite's Proprietary AI Powers Caregiver Solution Enables Contract Growth in Large Segments
Amesite's Hospice Documentation Addresses Key Pain in Market: Losses in Reimbursements Due to Deficient Documentation Amesite's Hospice Documentation Addresses Key Pain in Market: Losses in Reimbursements Due to Deficient Documentation
Automated Sales Process Has Successfully Enabled NurseMagic™ Enterprise Sales to Close within Hours of Enterprise Outreach Automated Sales Process Has Successfully Enabled NurseMagic™ Enterprise Sales to Close within Hours of Enterprise Outreach
DETROIT, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference is taking place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
DETROIT, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the closing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of $3.00 per share, before underwriting discounts and commissions, for an aggregate offering of approximately $3.6 million. Certain officers and directors of the Company participated in the offering for aggregate subscriptions of approximately $1.26 million.
DETROIT, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the pricing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of $3.00 per share, before underwriting discounts and commissions, for an aggregate offering of approximately $3.6 million. Certain officers and directors of the Company are participating in the offering for aggregate subscriptions of approximately $1.26 million. The offering is expected to close on January 8, 2025, subject to the satisfaction of customary closing conditions.
DETROIT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof) in a “best efforts” underwritten public offering. The proposed offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Company to Discuss Growth for NurseMagic™ for both B2C and B2B Users in 50 States and 21 Countries, Representing 87 Professions Company to Discuss Growth for NurseMagic™ for both B2C and B2B Users in 50 States and 21 Countries, Representing 87 Professions
Presentation Includes Discussion of Monetization of NurseMagic™ DETROIT, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today it will release an end of year video shareholder update to its website today, December 23, 2024 at 3:00 pm ET. The presentation will be available to shareholders here: https://ir.amesite.com/news-events/media.
Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in Healthcare Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in Healthcare